Delivery Order SPE2DB22D2206-SPE2DB25FEZ73
Award Date
1/7/25
Potential Completion Date
1/29/25
Potential Value
$48K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $36,698.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of POMALYST 3 MG CAPSULE 21S, a pharmaceutical product, with a completion date of May 14, 2024.
AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $12,287.90 firm-fixed-price delivery order is for the supply of POMALYST 2 MG CAPSULE 21S, a prescription medication. The contract has an ultimate completion date of May 13, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This is a $114,147.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pomalyst 1 mg capsules, a specialty medication used for the treatment of certain types of cancer. The contract has a period of performance through January 24, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of Pomalyst 3 mg capsules, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $82,217.47, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through November...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order worth $22,938.76 to provide 4564977355 POMALYST 2 MG CAPSULE 21S to the Defense Logistics Agency (DLA). The award is not set aside and is a firm fixed-price contract with a completion date of July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide POMALYST 4 MG CAPSULE 100S. The $230,031.96 contract has a completion date of September 8, 2021 and does not have a set-aside designation. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,781,412 units of the pharmaceutical product POMALYST 3 MG CAPSULE 100S. The $162,093.60 contract was awarded on April 4, 2022 with a completion date of April 25, 2022. Amerisourcebergen Drug Corp, which has an existing indefinite delivery contract with the Department of Justice Federal...
This is a federal contract award valued at $178,310.12 from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of REVLIMID 10 MG CAPSULE 100S, a prescription medication.
The contract is a firm fixed-price agreement with a period of performance through January 24, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This federal contract award, valued at $83,322.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of REVLIMID 5 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of January 13, 2023 and is a Firm Fixed Price arrangement.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,185.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...